Sale!

TRAPPC9 Gene Mental Retardation Autosomal Dominant Type 13 Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The TRAPPC9 Gene Mental Retardation Autosomal Dominant Type 13 Genetic Test is a specialized diagnostic procedure designed to identify mutations in the TRAPPC9 gene, which have been associated with a specific form of intellectual disability known as Autosomal Dominant Mental Retardation Type 13. This condition is characterized by various degrees of cognitive impairment, developmental delays, and in some cases, additional neurological or physical anomalies. The test is crucial for families seeking a definitive diagnosis, understanding the genetic basis of the condition, and making informed decisions about care and management.

Performed at DNA Labs UAE, a leading facility in genetic testing, this test involves collecting a DNA sample, typically through a blood draw or cheek swab, and examining the genetic material for specific mutations in the TRAPPC9 gene. The process employs advanced genetic sequencing technologies to ensure accurate and reliable results.

The cost of the TRAPPC9 Gene Mental Retardation Autosomal Dominant Type 13 Genetic Test is set at 4400 AED. While the price may seem significant, the value of obtaining a precise diagnosis cannot be understated, as it opens the door to targeted interventions, supports, and potentially participating in research studies aimed at finding treatments or understanding the condition better. Families considering this test are encouraged to consult with genetic counselors or specialists in genetic medicine to discuss the implications of the test results and the best path forward.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

TRAPPC9 Gene Mental Retardation Autosomal Dominant Type 13 Genetic Test

Welcome to DNA Labs UAE, where we offer the TRAPPC9 Gene Mental Retardation Autosomal Dominant Type 13 Genetic Test. This test is designed to identify mutations or variations in the TRAPPC9 gene that may be associated with mental retardation, autosomal dominant type 13 (MRD13).

Test Details

The TRAPPC9 gene is linked to MRD13, a genetic condition characterized by intellectual disability. Our NGS (Next-Generation Sequencing) technology allows us to analyze the DNA sequence of an individual’s genes and detect any variations or mutations that may be causing the intellectual disability.

By performing this genetic test, we can confirm a diagnosis, provide information about the specific genetic cause of the condition, and guide appropriate medical management and genetic counseling for affected individuals and their families.

Test Components

  • Test Name: TRAPPC9 Gene Mental Retardation Autosomal Dominant Type 13 Genetic Test
  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics

Pre Test Information

Prior to undergoing the TRAPPC9 Gene Mental Retardation Autosomal Dominant Type 13 NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by MRD13.

Please note that genetic testing should be performed and interpreted by qualified healthcare professionals who specialize in genetics, such as genetic counselors or medical geneticists. They can provide more detailed information about the specific implications and limitations of the test, as well as the potential benefits and risks associated with genetic testing.

Test Name TRAPPC9 Gene Mental retardation autosomal dominant type 13 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for TRAPPC9 Gene Mental retardation, autosomal dominant type 13 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with TRAPPC9 Gene Mental retardation, autosomal dominant type 13
Test Details

The TRAPPC9 gene is associated with mental retardation, autosomal dominant type 13 (MRD13), which is a genetic condition characterized by intellectual disability. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze the DNA sequence of an individual’s genes to identify any variations or mutations that may be associated with a particular condition.

In the case of MRD13, NGS genetic testing can be used to identify any mutations or variations in the TRAPPC9 gene that may be causing the intellectual disability. This type of testing can help in confirming a diagnosis, providing information about the specific genetic cause of the condition, and guiding appropriate medical management and genetic counseling for affected individuals and their families.

It is important to note that genetic testing should be performed and interpreted by qualified healthcare professionals who specialize in genetics, such as genetic counselors or medical geneticists. They can provide more detailed information about the specific implications and limitations of the test, as well as the potential benefits and risks associated with genetic testing.